<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37198993</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4286</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>16</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Current pharmaceutical design</Title><ISOAbbreviation>Curr Pharm Des</ISOAbbreviation></Journal><ArticleTitle>LncRNA GAS5 as an Inflammatory Regulator Acting through Pathway in Human Lupus.</ArticleTitle><Pagination><StartPage>1293</StartPage><EndPage>1299</EndPage><MedlinePgn>1293-1299</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1381612829666230517102205</ELocationID><Abstract><AbstractText Label="AIM">To investigate the contribution of GAS5 in the pathogenesis of SLE.</AbstractText><AbstractText Label="BACKGROUND">Systemic Lupus Erythematosus (SLE) is characterized by aberrant activity of the immune system, leading to variable clinical symptoms. The etiology of SLE is multifactor, and growing evidence has shown that long noncoding RNAs (lncRNAs) are related to human SLE. Recently, lncRNA growth arrest-specific transcript 5 (GAS5) has been reported to be associated with SLE. However, the mechanism between GAS5 and SLE is still unknown.</AbstractText><AbstractText Label="OBJECTIVE">Find the specific mechanism of action of lncRNA GAS5 in SLE.</AbstractText><AbstractText Label="METHODS">Collecting samples of the SLE patients, Cell culture and treatment, Plasmid construction, and transfection, Quantitative real-time PCR analysis, Enzyme-linked immunosorbent assay (ELISA), Cell viability analysis, Cell apoptosis analysis, Western blot.</AbstractText><AbstractText Label="RESULTS">In this research, we investigated the contribution of GAS5 in the pathogenesis of SLE. We confirmed that, compared to healthy people, the expression of GAS5 was significantly decreased in peripheral monocytes of SLE patients. Subsequently, we found that GAS5 can inhibit the proliferation and promote the apoptosis of monocytes by over-expressing or knocking down the expression of GAS5. Additionally, the expression of GAS5 was suppressed by LPS. Silencing GAS5 significantly increased the expression of a group of chemokines and cytokines, including IL-1&#x3b2;, IL-6, and THF&#x3b1;, which were induced by LPS. Furthermore, it was identified the involvement of GAS5 in the TLR4-mediated inflammatory process was through affecting the activation of the MAPK signaling pathway.</AbstractText><AbstractText Label="CONCLUSION">In general, the decreased GAS5 expression may be a potential contributor to the elevated production of a great number of cytokines and chemokines in SLE patients. And our research suggests that GAS5 contributes a regulatory role in the pathogenesis of SLE, and may provide a potential target for therapeutic intervention.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Deguang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Pharm Des</MedlineTA><NlmUniqueID>9602487</NlmUniqueID><ISSNLinking>1381-6128</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C561567">GAS5 long non-coding RNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GAS5</Keyword><Keyword MajorTopicYN="N">Long noncoding RNA</Keyword><Keyword MajorTopicYN="N">MAPK pathway</Keyword><Keyword MajorTopicYN="N">chemokines</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">monocytes</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest, financial or otherwise.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37198993</ArticleId><ArticleId IdType="pmc">PMC10339682</ArticleId><ArticleId IdType="doi">10.2174/1381612829666230517102205</ArticleId><ArticleId IdType="pii">CPD-EPUB-131852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiriakidou M., Ching C.L. Systemic lupus erythematosus. Ann. Intern. Med. 2020;172(11):ITC81&#x2013;ITC96. doi: 10.7326/AITC202006020.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202006020</ArticleId><ArticleId IdType="pubmed">32479157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagberg N., R&#xf6;nnblom L. Systemic lupus erythematosus-a disease with a dysregulated type I interferon system. Scand. J. Immunol. 2015;82(3):199&#x2013;207. doi: 10.1111/sji.12330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12330</ArticleId><ArticleId IdType="pubmed">26099519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A., Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 2008;358(9):929&#x2013;939. doi: 10.1056/NEJMra071297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra071297</ArticleId><ArticleId IdType="pubmed">18305268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F., Haas M., Glassock R., Zhao M.H. Redefining lupus nephritis: Clinical implications of pathophysiologic subtypes. Nat. Rev. Nephrol. 2017;13(8):483&#x2013;495. doi: 10.1038/nrneph.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.85</ArticleId><ArticleId IdType="pubmed">28669995</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel M., Alarc&#xf3;n-Riquelme M.E. The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned. J. Autoimmun. 2016;74:161&#x2013;175. doi: 10.1016/j.jaut.2016.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.08.001</ArticleId><ArticleId IdType="pubmed">27522116</ArticleId></ArticleIdList></Reference><Reference><Citation>Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., Xue C., Marinov G.K., Khatun J., Williams B.A., Zaleski C., Rozowsky J., R&#xf6;der M., Kokocinski F., Abdelhamid R.F., Alioto T., Antoshechkin I., Baer M.T., Bar N.S., Batut P., Bell K., Bell I., Chakrabortty S., Chen X., Chrast J., Curado J., Derrien T., Drenkow J., Dumais E., Dumais J., Duttagupta R., Falconnet E., Fastuca M., Fejes-Toth K., Ferreira P., Foissac S., Fullwood M.J., Gao H., Gonzalez D., Gordon A., Gunawardena H., Howald C., Jha S., Johnson R., Kapranov P., King B., Kingswood C., Luo O.J., Park E., Persaud K., Preall J.B., Ribeca P., Risk B., Robyr D., Sammeth M., Schaffer L., See L.H., Shahab A., Skancke J., Suzuki A.M., Takahashi H., Tilgner H., Trout D., Walters N., Wang H., Wrobel J., Yu Y., Ruan X., Hayashizaki Y., Harrow J., Gerstein M., Hubbard T., Reymond A., Antonarakis S.E., Hannon G., Giddings M.C., Ruan Y., Wold B., Carninci P., Guig&#xf3; R., Gingeras T.R. Landscape of transcription in human cells. Nature. 2012;489(7414):101&#x2013;108. doi: 10.1038/nature11233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11233</ArticleId><ArticleId IdType="pmc">PMC3684276</ArticleId><ArticleId IdType="pubmed">22955620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N., Tie C., Yu B., Zhang W., Wan J. Identifying lncRNA&#x2013;miRNA&#x2013;mRNA networks to investigate Alzheimer&#x2019;s disease pathogenesis and therapy strategy. Aging. 2020;12(3):2897&#x2013;2920. doi: 10.18632/aging.102785.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102785</ArticleId><ArticleId IdType="pmc">PMC7041741</ArticleId><ArticleId IdType="pubmed">32035423</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Z., Zhang Z., Liu H., Li W., Guo X., Zhang Z., Liu Y., Jia L., Li Y., Ren Y., Yang H., Zhang L., Zhang Q., Da Y., Hao J., Yao Z., Zhang R. lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation. Cell Death Differ. 2019;26(1):130&#x2013;145. doi: 10.1038/s41418-018-0105-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0105-8</ArticleId><ArticleId IdType="pmc">PMC6294802</ArticleId><ArticleId IdType="pubmed">29666475</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu L., Lou F., Sun Y., Sun L., Cai X., Liu Z., Zhou H., Wang H., Wang Z., Bai J., Yin Q., Zhang J., Chen L., Peng D., Xu Z., Gao Y., Tang S., Fan L., Wang H. A micropeptide encoded by lncRNA MIR155HG suppresses autoimmune inflammation via modulating antigen presentation. Sci. Adv. 2020;6(21):eaaz2059. doi: 10.1126/sciadv.aaz2059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz2059</ArticleId><ArticleId IdType="pmc">PMC7314557</ArticleId><ArticleId IdType="pubmed">32671205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J., Ma Y.X., Liu Z.H., Zeng Y.L. LncRNA SNHG7 contributes to cell proliferation, invasion and prognosis of cervical cancer. Eur. Rev. Med. Pharmacol. Sci. 2019;23(21):9277&#x2013;9285.</Citation><ArticleIdList><ArticleId IdType="pubmed">31773679</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li L., Wang Z., Pan T., Sahni N., Jin X., Wang G., Li J., Zheng X., Zhang Y., Xu J., Yi S., Li X. LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations. Nucleic Acids Res. 2018;46(3):1113&#x2013;1123. doi: 10.1093/nar/gkx1311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1311</ArticleId><ArticleId IdType="pmc">PMC5815097</ArticleId><ArticleId IdType="pubmed">29325141</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yin L., Chen C., Zhang X., Wang S. Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein. Dig. Liver Dis. 2020;52(3):331&#x2013;338. doi: 10.1016/j.dld.2019.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2019.08.012</ArticleId><ArticleId IdType="pubmed">31530437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Meng L., Zhong Y., Hu F., Wang L., Wang M. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis. Aging. 2021;13(2):2864&#x2013;2884. doi: 10.18632/aging.202352.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202352</ArticleId><ArticleId IdType="pmc">PMC7880381</ArticleId><ArticleId IdType="pubmed">33418541</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Pang X., Shang W., Xie H., Feng Y., Feng G. RETRACTED ARTICLE: Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway. Cell Cycle. 2019;18(3):257&#x2013;263. doi: 10.1080/15384101.2018.1475826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2018.1475826</ArticleId><ArticleId IdType="pmc">PMC6380417</ArticleId><ArticleId IdType="pubmed">29895198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Li Y., Li M., Wang L. Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma. Am. J. Cancer Res. 2019;9(1):108&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6356919</ArticleId><ArticleId IdType="pubmed">30755815</ArticleId></ArticleIdList></Reference><Reference><Citation>Esguerra J.L.S., Ofori J.K., Nagao M., Shuto Y., Karagiannopoulos A., Fadista J., Sugihara H., Groop L., Eliasson L. Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA. Mol. Metab. 2020;32:160&#x2013;167. doi: 10.1016/j.molmet.2019.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2019.12.012</ArticleId><ArticleId IdType="pmc">PMC6976904</ArticleId><ArticleId IdType="pubmed">32029226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg M.C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D.D., Iba&#xf1;ez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 2002;29(2):288&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J., Wang J., Yuan L., Hao L., Wang D. Study on the mechanism and intervention strategy of sunitinib induced nephrotoxicity. Eur. J. Pharmacol. 2019;864:172709. doi: 10.1016/j.ejphar.2019.172709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172709</ArticleId><ArticleId IdType="pubmed">31586633</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G.C., Hu Y., Guan S.Y., Ye D.Q., Pan H.F. Differential plasma expression profiles of long non-coding RNAs reveal potential biomarkers for systemic lupus erythematosus. Biomolecules. 2019;9(6):206. doi: 10.3390/biom9060206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9060206</ArticleId><ArticleId IdType="pmc">PMC6627908</ArticleId><ArticleId IdType="pubmed">31141998</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibler C., John S., Elsner R.A., Thomas K.B., Smita S., Joachim S., Levack R.C., Callahan D.J., Gordon R.A., Bastacky S., Fukui R., Miyake K., Gingras S., Nickerson K.M., Shlomchik M.J. Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus. Nat. Immunol. 2022;23(10):1457&#x2013;1469. doi: 10.1038/s41590-022-01310-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01310-2</ArticleId><ArticleId IdType="pmc">PMC9561083</ArticleId><ArticleId IdType="pubmed">36151396</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokogawa M., Takaishi M., Nakajima K., Kamijima R., Fujimoto C., Kataoka S., Terada Y., Sano S. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus. Arthritis Rheumatol. 2014;66(3):694&#x2013;706. doi: 10.1002/art.38298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38298</ArticleId><ArticleId IdType="pubmed">24574230</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldner H. The role of innate immune responses in autoimmune disease development. Autoimmun. Rev. 2009;8(5):400&#x2013;404. doi: 10.1016/j.autrev.2008.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.12.019</ArticleId><ArticleId IdType="pubmed">19162250</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Lee P.Y., Reeves W.H. Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch. Immunol. Ther. Exp. (Warsz.) 2010;58(5):355&#x2013;364. doi: 10.1007/s00005-010-0093-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-010-0093-y</ArticleId><ArticleId IdType="pmc">PMC3785254</ArticleId><ArticleId IdType="pubmed">20676786</ArticleId></ArticleIdList></Reference><Reference><Citation>Funauchi M., Ohno M., Minoda M., Horiuchi A. Abnormal expression of intercellular adhesion molecule-1 on peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J. Clin. Lab. Immunol. 1993;40(3):115&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">7877151</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsiari C.G., Liossis S.N.C., Souliotis V.L., Dimopoulos A.M., Manoussakis M.N., Sfikakis P.P. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 2002;103(1):54&#x2013;62. doi: 10.1006/clim.2001.5172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clim.2001.5172</ArticleId><ArticleId IdType="pubmed">11987985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyttaris V.C., Juang Y.T., Tsokos G.C. Immune cells and cytokines in systemic lupus erythematosus: An update. Curr. Opin. Rheumatol. 2005;17(5):518&#x2013;522. doi: 10.1097/01.bor.0000170479.01451.ab.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.bor.0000170479.01451.ab</ArticleId><ArticleId IdType="pubmed">16093827</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara E., Gourley M.F., Lee S., Klinman D.M. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-&#x3b3;&#x2013;secreting cells in the peripheral blood. Arthritis Rheum. 1996;39(3):379&#x2013;385. doi: 10.1002/art.1780390305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780390305</ArticleId><ArticleId IdType="pubmed">8607886</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema G.S., Roschke V., Hilbert D.M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001;44(6):1313&#x2013;1319. doi: 10.1002/1529-0131(200106)44:6&lt;1313::AID-ART223&gt;3.0.CO;2-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200106)44:6&lt;1313::AID-ART223&gt;3.0.CO;2-S</ArticleId><ArticleId IdType="pubmed">11407690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Roschke V., Baker K.P., Wang Z., Alarc&#xf3;n G.S., Fessler B.J., Bastian H., Kimberly R.P., Zhou T. Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 2001;166(1):6&#x2013;10. doi: 10.4049/jimmunol.166.1.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.1.6</ArticleId><ArticleId IdType="pubmed">11123269</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wu G.C., Zhang T.P., Yang X.K., Chen S.S., Li L.J., Xu S.Z., Lv T.T., Leng R.X., Pan H.F., Ye D.Q. Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus. Sci. Rep. 2017;7(1):15119. doi: 10.1038/s41598-017-15156-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15156-4</ArticleId><ArticleId IdType="pmc">PMC5680319</ArticleId><ArticleId IdType="pubmed">29123179</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Zhou T., Yu X., Xue Z., Shen N. The role of long non-coding RNAs in rheumatic diseases. Nat. Rev. Rheumatol. 2017;13(11):657&#x2013;669. doi: 10.1038/nrrheum.2017.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2017.162</ArticleId><ArticleId IdType="pubmed">28978995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills K.H.G. TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 2011;11(12):807&#x2013;822. doi: 10.1038/nri3095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3095</ArticleId><ArticleId IdType="pubmed">22094985</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttman M., Amit I., Garber M., French C., Lin M.F., Feldser D., Huarte M., Zuk O., Carey B.W., Cassady J.P., Cabili M.N., Jaenisch R., Mikkelsen T.S., Jacks T., Hacohen N., Bernstein B.E., Kellis M., Regev A., Rinn J.L., Lander E.S. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223&#x2013;227. doi: 10.1038/nature07672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07672</ArticleId><ArticleId IdType="pmc">PMC2754849</ArticleId><ArticleId IdType="pubmed">19182780</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wu L., Qian J., Qu B., Xia S., La T., Wu Y., Ma J., Zeng J., Guo Q., Cui Y., Yang W., Huang J., Zhu W., Yao Y., Shen N., Tang Y. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. J. Autoimmun. 2016;75:96&#x2013;104. doi: 10.1016/j.jaut.2016.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.07.012</ArticleId><ArticleId IdType="pubmed">27481557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao S., Shao Z. HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis. Int. J. Clin. Exp. Pathol. 2015;8(6):7223&#x2013;7228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525952</ArticleId><ArticleId IdType="pubmed">26261618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Yuan B., Flygare J., Lodish H.F. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev. 2011;25(24):2573&#x2013;2578. doi: 10.1101/gad.178780.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.178780.111</ArticleId><ArticleId IdType="pmc">PMC3248679</ArticleId><ArticleId IdType="pubmed">22155924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>